COMPARISON OF CYCLOPHOSPHAMIDE ( CYTOXAN ) + URACIL MUSTARD ) U-8344 ) IN CHRONIC GRANULOCYTIC LEUKEMIA

被引:0
|
作者
FROMMEYER, WB
机构
关键词
D O I
10.1002/1097-0142(196403)17:3<288::AID-CNCR2820170303>3.0.CO;2-Y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:288 / &
相关论文
共 38 条
  • [21] CHEMOTHERAPY OF BLASTIC PHASE OF CHRONIC GRANULOCYTIC LEUKEMIA - PROSPECTIVE COMPARISON OF VINCRISTINE PREDNISONE WITH CYTOSINE ARABINOSIDE-6-THIOGUANINE AND EFFECT OF PRIOR SPLENECTOMY
    CANELLOS, GP
    YOUNG, RC
    CHABNER, BA
    SCHEIN, PS
    WHANGPENG, J
    DEVITA, VT
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 252 - 252
  • [22] Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation
    Copelan, Edward A.
    Avalos, Belinda R.
    Ahn, Kwang Woo
    Zhu, Xiaochun
    Gale, Robert Peter
    Grunwald, Michael R.
    Hamadani, Mehdi
    Hamilton, Betty K.
    Hale, Gregory A.
    Marks, David I.
    Waller, Edmund K.
    Savani, Bipin N.
    Costa, Luciano J.
    Ramanathan, Muthalagu
    Cahn, Jean-Yves
    Khoury, H. Jean
    Weisdorf, Daniel J.
    Inamoto, Yoshihiro
    Kamble, Rammurti T.
    Schouten, Harry C.
    Wirk, Baldeep
    Litzow, Mark R.
    Aljurf, Mahmoud D.
    van Besien, Koen W.
    Ustun, Celalettin
    Bolwell, Brian J.
    Bredeson, Christopher N.
    Fasan, Omotayo
    Ghosh, Nilanjan
    Horowitz, Mary M.
    Arora, Mukta
    Szer, Jeffrey
    Loren, Alison W.
    Alyea, Edwin P.
    Cortes, Jorge
    Maziarz, Richard T.
    Kalaycio, Matt E.
    Saber, Wael
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (03) : 552 - 558
  • [23] Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study)
    Robak, Tadeusz
    Jamroziak, Krzysztof
    Gora-Tybor, Joanna
    Stella-Holowiecka, Beata
    Konopka, Lech
    Ceglarek, Bernadetta
    Warzocha, Krzysztof
    Seferynska, Ilona
    Piszcz, Jaroslaw
    Calbecka, Malgorzata
    Kostyra, Aleksandra
    Dwilewicz-Trojaczek, Jadwiga
    Dmoszynska, Anna
    Zawilska, Krystyna
    Hellmann, Andrzej
    Zdunczyk, Andrzej
    Potoczek, Stanislaw
    Piotrowska, Magdalena
    Lewandowski, Krzysztof
    Blonski, Jerzy Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1863 - 1869
  • [24] COMPARISON OF FLUDARABINE, CYCLOPHOSPHAMIDE DOXORUBICIN PREDNISONE, AND CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE IN ADVANCED FORMS OF CHRONIC LYMPHOCYTIC-LEUKEMIA - PRELIMINARY-RESULTS OF A CONTROLLED CLINICAL-TRIAL
    FENAUX, P
    BINET, JL
    MALOUM, K
    LEPORRIER, M
    RAPP, MJ
    PIGUET, H
    BRION, A
    BOUDJERRA, N
    DREYFUS, B
    LEBLAY, R
    STOPPA, AM
    AUTRAND, JP
    SEBBAN, C
    PAITEL, JF
    MAISONNEUVE, P
    ROUSSET, T
    LINASSIER, M
    BRICE, P
    TRAVADE, P
    DIVINE, M
    DESABLENS, B
    JAUBERT, J
    ALLARD, C
    CHERON, D
    EGHBALI, JP
    CELIGNY, PS
    BORDESSOULE, D
    PIGNON, B
    VAUGIER, G
    LEJEUNE, F
    SALLES, B
    DEVIDAS, M
    BLANC, M
    MAIGRE, M
    REIGNER, A
    SIMON, P
    CHRISTIAN, B
    SCHVED, JF
    DOIRON, P
    RODON, M
    CARDE, P
    YAKOUB, I
    SOUTEYRAND, P
    RENOUX, M
    FACQUETDANIS, J
    HAMIDOU, M
    TURPIN, F
    DOR, JF
    FERMAND, JP
    VIGNERON, N
    SEMINARS IN ONCOLOGY, 1993, 20 (05) : 21 - 23
  • [25] Comparison of fludarabine (F), cyclophosphamide (C), and rituximab (R) versus FCR plus bevacizumab (B) in relapse chronic lymphocytic leukemia (CLL)
    Lee, Hun Ju
    Wierda, William G.
    Ferrajoli, Alessandra
    Burger, Jan Andreas
    Trinh, Long
    Lerner, Susan
    Keating, Michael J.
    O'Brien, Susan Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] MINIMAL RESIDUAL DISEASE DETECTED BY THE PCR IN CHRONIC MYELOID-LEUKEMIA - COMPARISON OF CYCLOPHOSPHAMIDE-TOTAL BODY IRRADIATION AND BUSULFAN-CYCLOPHOSPHAMIDE BONE-MARROW TRANSPLANTATION CONDITIONING
    STARK, RA
    RICHARD, P
    DEVERGIE, A
    GALIBERT, F
    GLUCKMAN, E
    ACTA HAEMATOLOGICA, 1993, 89 (02) : 108 - 109
  • [27] Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3)
    Robak, Tadeusz
    Blonski, Jerzy Z.
    Jamroziak, Krzysztof
    Gora-Tybor, Joanna
    Stella-Holowiecka, Beata
    Konopka, Lech
    Ceglarek, Bernadeta
    Warzocha, Krzysztof
    Seferynska, Ilona
    Kloczko, Janusz
    Piszcz, Jaroslaw
    Calbecka, Malgorzata
    Kostyra, Aleksandra
    Dwilewicz-Trojaczek, Jadwiga
    Wiater, Elzbieta
    Dmoszynska, Anna
    Kowal, Malgorzata
    Zawilska, Krystyna
    Grzywacz, Alina
    Hellmann, Andrzej
    Mital, Andrzej
    Zdunczyk, Andrzej
    Dybowicz, Jacck
    Kuliczkowski, Kazimierz
    Potoczek, Stanislaw
    Skotnicki, Aleksander
    Nowakowska-Domagala, Maria
    Lewandowski, Krzysztf
    Sulek, Kazimierz
    BLOOD, 2008, 112 (11) : 732 - 732
  • [28] COMPARISON OF RELATIVE RATES OF FORMATION OF NEW LEUKOCYTES IN MYLERAN TREATED AND UNTREATED PATIENTS WITH CHRONIC GRANULOCYTIC LEUKEMIA - MEASURED BY UPTAKE OF RADIOACTIVE PHOSPHORUS IN ISOLATED DESOXYRIBONUCLEIC ACID
    LI, JG
    LEONARD, ME
    HARRISON, G
    AMERICAN JOURNAL OF MEDICINE, 1955, 19 (02): : 293 - 293
  • [29] INVIVO DNA CROSS-LINKING BY CYCLOPHOSPHAMIDE - COMPARISON OF HUMAN CHRONIC LYMPHATIC-LEUKEMIA CELLS WITH MOUSE L1210 LEUKEMIA AND NORMAL BONE-MARROW CELLS
    DENEVE, W
    VALERIOTE, F
    EDELSTEIN, M
    EVERETT, C
    BISCHOFF, M
    CANCER RESEARCH, 1989, 49 (13) : 3452 - 3456
  • [30] NON-SUPRALETHAL MITOBRONITOL CYTARABINE CYCLOPHOSPHAMIDE CONDITIONING WITHOUT IRRADIATION BEFORE BONE-MARROW TRANSPLANTATION FOR ACCELERATED CHRONIC GRANULOCYTIC-LEUKEMIA - APPARENT ABSENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE
    KELEMEN, E
    JAKAB, K
    VARADI, G
    JANOSSA, M
    FOLDI, J
    DENES, R
    LEUKEMIA, 1993, 7 (07) : 939 - 945